OptimizeRx (OPRX) Gross Profit (2013 - 2026)

OptimizeRx (OPRX) has 14 years of Gross Profit data on file, last reported at $14.9 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 11.9% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2026 stood at $75.2 million (up 24.23% YoY), and the FY2025 full-year result was $73.6 million, up 23.94% from the prior year.
• Gross Profit eased to $14.9 million in Q1 2026, from $24.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $24.1 million in Q4 2025 to a low of $7.4 million in Q1 2023.
• A 5-year average of $13.5 million and a median of $12.5 million in 2022 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit decreased 12.96% in 2023 and soared 64.19% in 2024, its largest moves.
• Tracing OPRX's Gross Profit over 5 years: stood at $12.5 million in 2022, then jumped by 43.25% to $17.8 million in 2023, then increased by 23.44% to $22.0 million in 2024, then grew by 9.43% to $24.1 million in 2025, then plunged by 38.04% to $14.9 million in 2026.
• Business Quant data shows OPRX's Gross Profit at $14.9 million in Q1 2026, $24.1 million in Q4 2025, and $17.5 million in Q3 2025.